172 related articles for article (PubMed ID: 15276085)
1. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.
Piver B; Fer M; Vitrac X; Merillon JM; Dreano Y; Berthou F; Lucas D
Biochem Pharmacol; 2004 Aug; 68(4):773-82. PubMed ID: 15276085
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
3. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
6. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A1/2 mediated metabolism of trans-stilbene in rats and humans.
Sanoh S; Kitamura S; Sugihara K; Ohta S
Biol Pharm Bull; 2002 Mar; 25(3):397-400. PubMed ID: 11913543
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
[TBL] [Abstract][Full Text] [Related]
12. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
13. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
14. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
15. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
[TBL] [Abstract][Full Text] [Related]
17. A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.
Ohyama K; Nakajima M; Nakamura S; Shimada N; Yamazaki H; Yokoi T
Drug Metab Dispos; 2000 Nov; 28(11):1303-10. PubMed ID: 11038157
[TBL] [Abstract][Full Text] [Related]
18. Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.).
Guo J; Nikolic D; Chadwick LR; Pauli GF; van Breemen RB
Drug Metab Dispos; 2006 Jul; 34(7):1152-9. PubMed ID: 16611861
[TBL] [Abstract][Full Text] [Related]
19. Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2.
Clement B; Demesmaeker M
Drug Metab Dispos; 1997 Nov; 25(11):1266-71. PubMed ID: 9351903
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism of BDE-99 by human liver microsomes: predominant role of CYP2B6.
Erratico CA; Szeitz A; Bandiera SM
Toxicol Sci; 2012 Oct; 129(2):280-92. PubMed ID: 22738989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]